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ABSTRACT
BACKGROUND: Insulin resistance (IR) and progressive pancreatic β-cell dysfunction have been identi-
fied as the two fundamental features in the pathogenesis of obesity and non-insulin-dependent diabetes 
mellitus. We aimed to investigate correlations between anthropometric indices of obesity and IR in non-
diabetic obese individuals, and the cutoff value from receiver operating characteristic (ROC) curve analysis. 
DESIGN AND SETTING: Cross-sectional study conducted in a private clinic. 
METHODS: We included obese individuals (body mass index, BMI ≥ 30 kg/m2) with no diabetes mellitus 
(fasting glucose levels ≤ 126 mg/dl). The participants were evaluated for the presence of cardiovascu-
lar risk factors and through anthropometric measurements and biochemical tests. Furthermore, IR was 
assessed indirectly using the homeostatic model assessment (HOMA)-IR and HOMA-β indexes. The area 
under the curve (AUC) of the variables was compared. The sensitivity, specificity and cutoff of each variable 
for diagnosing IR were calculated.
RESULTS: The most promising anthropometric parameters for indicating IR in non-diabetic obese indi-
viduals were waist-to-height ratio (WHtR), waist circumference (WC) and BMI. WHtR proved to be an in-
dependent predictor of IR, with risk increased by 0.53% in HOMA-IR, 5.3% in HOMA-β and 1.14% in insulin. 
For HOMA-IR, WHtR had the highest AUC value (0.98), followed by WC (0.93) and BMI (0.81). For HOMA-β, 
WHtR also had the highest AUC value (0.83), followed by WC (0.75) and BMI (0.73). The optimal WHtR cutoff 
was 0.65 for HOMA-IR and 0.67 for HOMA-β.
CONCLUSION: Among anthropometric obesity indicators, WHtR was most closely associated with occur-
rences of IR and predicted the onset of diabetes in obese individuals.
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Insulin resistance (IR) is considered to be one of the main risk factors for cardiovascular disease 
(CVD). It is associated with several metabolic abnormalities such as impaired glucose tolerance, non-
insulin-dependent diabetes mellitus (NIDDM), hypertension and dyslipidemia.1,2 Maintenance of 
normal blood glucose comes mainly from the ability of β-pancreatic cells to secrete insulin and the 
sensitivity of the target tissues to respond to normal levels of insulin in the bloodstream.3
The homeostasis model assessment (HOMA) is a widely validated clinical and epidemiologi-
cal tool for estimating IR and β-cell function. It is derived from a mathematical assessment of 
the balance between hepatic glucose output and insulin secretion from fasting levels of glucose 
and insulin.4 HOMA-IR and HOMA-β have been adopted as an alternative to the gold standard 
method, i.e. the hyperinsulinemic-euglycemic clamp technique. Although use of HOMA indices 
requires an invasive access,5 it is inexpensive and easy to apply.6
One aspect of research on obesity that is currently attracting attention is the distribution of 
fat in the body. Diabetes, atherosclerosis and sudden cardiac death occur quite frequently among 
obese people, but when obesity is centralized in the abdominal region, the negative repercussions 
(both metabolic and cardiovascular) are more significant.7 Several studies have evaluated the cor-
relation between IR and anthropometric indices of obesity such as body mass index (BMI), waist 
circumference (WC), neck circumference (NC) and hip circumference (HP). They have dem-
onstrated that the distribution of visceral fat causes significant damage to the insulin-signaling 
pathway due to secretion of adipokines, e.g. C-reactive protein (CRP),2,8,9 thus leading to increased 
cardiometabolic risk.10 Therefore, obesity is the most prominent predictor of IR and diabetes.11
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Anthropometry is considered to be a non-invasive tool for 
early diagnosis of the onset of NIDDM. In addition, it provides 
an alternative evaluation of IR at lower cost that is accessible for 
application in epidemiological studies and primary care within 
health services.8 However, there is no consensus regarding which 
anthropometric measurement is most indicative of IR in non-dia-
betic obese subjects, or regarding the cutoff values.
OBJECTIVE
We aimed to investigate the correlations between anthropomet-
ric indices of obesity and IR in non-diabetic obese individuals, 
and to identify the best cutoff values of these indices for predict-




This study used a cross-sectional design. The participants were 
selected as a convenience sample of consecutive patients admit-
ted between 2013 and 2015, when they presented the following 
inclusion criteria: BMI ≥ 30 kg/m2 and no diabetes mellitus (DM) 
(reported or fasting blood glucose ≤ 126 mg/dl).12,13 We enrolled 
136 obese individuals, comprising 72 men and 64 women, at the 
Obesity Clinic of the Angiocorpore Institute of Cardiovascular 
Medicine, located in the city of Santos, São Paulo, Brazil. They 
had been referred for the examinations because of a variety of 
medical indications. This study formed part of a larger study 
assessing the determinants of exercise intolerance among obese 
individuals. All the participants agreed to participate, and none 
of them presented abnormalities during the examinations that 
would exclude them. 
The Ethics Committee for Research on Human Beings of 
the Federal University of São Paulo (Universidade Federal de 
São Paulo, UNIFESP) approved this study under the number 
1.079.239. Furthermore, an informed consent statement was signed 
by all of these volunteers.
Anthropometric obesity indices
Body weight and height were measured by using a weighing 
scale with stadiometer that measured to precisions of the near-
est 0.1 kg and 1 cm (Toledo, São Paulo, Brazil). The individu-
als were weighed without shoes. The neck (NC), waist (WC) 
and hip (HC) circumferences were measured in cm using an 
inelastic tape (Sanny) with precision of 1 mm. We measured 
NC at the midpoint of the neck; WC at the midpoint between 
the last rib and the iliac crest; and HC at the point of greatest 
gluteal protuberance.14,15 From these anthropometric measure-
ments, we obtained indices relating to cardiometabolic health: 
waist-to-hip ratio (WHR), waist/height ratio (WHtR), body 
mass index (BMI = weightkg/heightm²) and body shape index 
(BSI = WC/BMI2/3 x height½).16
Blood test
Blood samples were collected for laboratory-based biochemi-
cal measurements after the participants had fasted for 12 hours. 
We quantified C-reactive protein (CRP, ng/ml), total cholesterol 
(mg/dl), HDL cholesterol (mg/dl), LDL cholesterol (mg/dl), 
insulin (IU/dl) and glucose (mg/dl). Glucose values were con-
verted from mg/dl to mmol/l using the conversion factor 0.555.13
IR assessment
We used the homeostasis model assessments HOMA-IR and 
HOMA-β to indirectly determine IR, based on glucose and insu-
lin values proposed by Matthews et al.3 IR was defined as situa-
tions with HOMA-IR ≥ 2.7,17-21 and dysfunction of β-cells as situ-
ations with HOMA-β > 175.4,22
Cardiovascular risk assessment
We assessed self-reported cardiovascular risk factors in accor-
dance with the recommendations of the American College of 
Sports Medicine (ACSM). The participants were asked to report 
any previous diagnosis of the main cardiovascular risk factors 
such as arterial hypertension, dyslipidemia and diabetes, along 
with their age, situation of physical inactivity and smoking sta-
tus. We considered that the participants were physically inactive 
if they reported doing less than 150 minutes per week of moder-
ate-to-vigorous physical activity.23
Statistical analysis
We assessed correlations between anthropometric indices and 
HOMA-IR values, HOMA-β values and insulin concentration 
using Pearson correlation coefficients. Three models of stepwise 
multiple linear regressions were then fitted, with HOMA-IR, 
HOMA-β and insulin as the main outcomes. The main predictors 
that we chose were the anthropometric indices that significantly 
correlated with outcomes after univariate analysis. We checked 
for multicollinearity in the models by means of variation infla-
tion factor (VIF) values < 4. The models were also adjusted for 
age, sex and cardiovascular risk factors.
We fitted ROC curves to assess the best cutoff points for 
anthropometric measurements for predicting clinically high val-
ues of HOMA-IR and HOMA-β as surrogate measurements for 
IR. The areas under the ROC curves (AUC) and the 95% confi-
dence intervals (95% CI) were used to compare the diagnostic 
value of various obesity indices. We considered that values above 
0.80 were excellent. The main anthropometric indices selected after 
multiple linear regression were used to obtain the optimal cutoff 
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point for diagnosing IR. We calculated the sensitivity, specificity, 
positive and negative likelihood ratios and Youden index in rela-
tion to these values. 
All tests were evaluated at a two-tailed alpha level of 0.05. 
All statistical analyses were performed using the Statistical Package 
for the Social Sciences (SPSS), version 23 (SPSS Inc., Chicago, 
USA), and the MedCalc package, version 17 (MedCalc Software 
bvba, Belgium).
RESULTS
Baseline characteristics of the participants
The men and women involved in the present study were on aver-
age middle-aged. We found significantly higher values for weight, 
height, WC, WHR, NC and BSI among the men, while HC and 
BMI were significantly higher among the women. The partici-
pants were mostly physically inactive. We observed a greater pro-
portion of dyslipidemia among the men and higher fasting glu-
cose among the women (Table 1).
When stratified according to nutritional status, we found 
progressively impaired values for fasting insulin, HOMA-IR and 
HOMA-β with increasing severity of obesity, while CRP presented 
a significant difference only at obesity level I and total cholesterol 
at obesity level III (Table 2).
Correlation and multiple regression analysis
We found strong correlations of WHtR, WC and BMI with 
HOMA-IR, HOMA-β and fasting insulin. On the other hand, 
WHR, NC and BSI showed weak correlations (Table 3). A step-
wise multiple linear regression analysis was performed with 
HOMA-IR, HOMA-β and insulin as dependent variables. 
After adjustment for age, sex and obesity indices, WHtR proved 
to be an independent predictor of IR in this study (Table 4).
ROC curves
The abilities of WHtR, WC and BMI to detect IR were com-
pared using ROC curves. For HOMA-IR, we found an AUC 
of 0.98 for WHtR, 0.83 for WC and 0.81 for BMI, such that 
the AUC was significantly greater for WHtR than for WC 
(difference between areas = 0.150; P < 0.001) and BMI (dif-
ference between areas = 0.171; P < 0.001). We found that 
there was no significant difference in AUC between WC 
and BMI (difference between areas = 0.021; P = 0.629) 
(Figure 1). Regarding HOMA-β, the AUC of 0.83 for WHtR 
Table 1. General characteristics of the study sample according to sex. 






Age (years) 37 ± 10 34 ± 8 0.054
Weight (kg) 106 ± 11 120 ± 17* 0.000
Height (m) 1.62 ± 0.05 1.75 ± 0.08* 0.000
Body mass index (kg/m2) 40.5 ± 4.8 38.8 ± 4.5* 0.034
Waist circumference (cm) 111 ± 8 118 ± 11* 0.000
Hip circumference (cm) 129 ± 9 120 ± 9* 0.000
Waist-to-hip ratio 0.86 ± 0.07 0.98 ± 0.07* 0.000
Neck circumference (cm) 38 ± 3 44 ± 3* 0.000
Body shape index 7.4 ± 0.4 7.8 ± 0.45* 0.000
Waist-to-height ratio 0.69 ± 0.06 0.68 ± 0.06 0.333
Cardiovascular risk assessment and biochemical analysis 
Arterial hypertension 20 (23.8) 15 (20.0) 0.592
Dyslipidemia 10 (11.9) 21 (28.0)* 0.020
Physical inactivity 63 (75.0) 55 (73.3) 0.821
Current smoking 13 (15.4) 14 (18.6) 0.620
HDL (mg/dl) 50 ± 15 50 ± 13 1.000
LDL (mg/dl) 115 ± 32 121 ± 34 0.292
Total cholesterol (mg/dl) 196 ± 38 201 ± 32 0.406
Fasting glucose (mg/dl) 93 ± 10 89 ± 11* 0.028
Fasting insulin (IU/ml) 19 ± 9 17 ± 10 0.224
HOMA-IR 4.72 ± 2.58 3.81 ± 2.50 0.058
HOMA-β 71.6 ± 35.8 64.9 ± 42.9 0.327
HDL = high-density lipoprotein; LDL = low-density lipoprotein; HOMA-IR = homeostasis 
model assessment - insulin resistance; HOMA-β = homeostasis model assessment 
- beta-cell function. 
*P < 0.05 = females versus males.
Table 2. Description of anthropometric measurements and 









Weight (kg) 101 ± 10.5 108 ± 12.0 124 ± 15.6d
Height (cm) 172 ± 0.0 169 ± 0.0 166 ± 0.0b
Waist circumference (cm) 107 ± 6 113 ± 8 121 ± 10d
Hip circumference (cm) 115 ± 4.6 121 ± 7.2 133 ± 8.8ad
Neck circumference (cm) 40 ± 3.1 41 ± 4.2 41 ± 4.8
Waist-to-hip ratio 0.93 ± 0.07 0.93 ± 0.89 0.90 ± 0.10
Waist-to-height ratio 0.62 ± 0.03 0.67 ± 0.05 0.73 ± 0.06ad
Body mass index (kg/m2) 33.8 ± 0.8 37.6 ± 1.3 44.9 ± 3.6ad
Body shape index 7.8 ± 0.4 7.7 ± 0.5 7.4 ± 0.5bc
Biochemical analysis 
C-reactive protein (ng/ml) 2.15 ± 2.86 0.93 ± 1.15 0.92 ± 0.98e
Total cholesterol (mg/dl) 198 ± 35 191 ± 32 208 ± 38c
HDL (mg/dl) 53 ± 16 48 ± 13 51 ± 14
LDL (mg/dl) 124 ± 25 116 ± 27 119 ± 43
Fasting glucose (mg/dl) 88 ± 9 91 ± 11 93 ± 11
Fasting insulin (IU/ml) 9.6 ± 4.0 15.0 ± 6.2 25.6 ± 11.6d
HOMA-IR 2.1 ± 1.0 3.4 ± 1.6 6.0 ± 2.8d
HOMA-β 35.5 ± 15 55.7 ± 23 95.3 ± 45d
HDL = high-density lipoprotein; LDL = low-density lipoprotein; HOMA-
IR = homeostasis model assessment - insulin resistance; HOMA- β = 
homeostasis model assessment - beta-cell function. 
a = obesity I versus obesity II, P < 0.05. b: obesity I versus obesity III, P < 0.05. 
c = obesity II versus obesity III, P < 0.05. d = obesity I and obesity II versus 
obesity III, P < 0.05. e: obesity II and obesity III versus obesity I, P < 0.05. 
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was significantly greater than the AUC for WC (0.75, differ-
ence between areas = 0.082; P = 0.013) and BMI (0.73, dif-
ference between areas = 0.099; P = 0.009), with no signifi-
cant difference between WC and BMI (difference between 
areas = 0.017; P = 0.727) (Figure 2). The best cutoff points 
for HOMA-IR were 0.65, 113 cm and 38.76 kg/m2 and for 
HOMA-β were 0.67, 112 cm and 37.61 kg/m2, respectively 
for WHtR, WC and BMI (Table 5). 
DISCUSSION
In the present study, we observed that not all the anthropometric 
parameters studied were significantly associated with HOMA-IR 
and HOMA-β. The most promising anthropometric parameters 
for indicating IR in non-diabetic obese adults were WHtR, WC 
and BMI. Our results suggest that there are advantages to using 
WHtR. In our analysis, we observed that the risk of IR was raised 
by 0.53% in HOMA-IR, 5.3% in HOMA-β and 1.14% in insulin for 
each additional 1% increase in WHtR (= 0.01). Thus, WHtR was 
a predictor for the degree of IR and predisposition towards dia-
betes in our sample of obese individuals. Recently, Vikam et al.10 
observed increased odds ratios for hyperinsulinemia and meta-
bolic syndrome among individuals with WHtR > 0.5.
Use of WHtR for detecting abdominal obesity and its associ-
ated risks to health was first proposed in the 1990s.24 The growing 
Table 3. Matrix of correlations between obesity indices and values for homeostasis model assessment - insulin resistance (HOMA-IR) and 
for HOMA - beta-cell function (HOMA-β) in the study sample 
HOMA-IR HOMA-β Insulin (IU/ml) WHtR WC (cm) BMI (kg/m2) WHR NC (cm) BSI
HOMA-IR
r 1 0.853* 0.920* 0.846* 0.648* 0.669* 0.164 0.114 0.197†
p 0.00 0.00 0.00 0.00 0.00 0.061 0.197 0.024
p† 0.086 0.334 0.242 0.974 0.399 0.377 0.377 0.019
HOMA-β
r 0.753* 1 0.944* 0.905* 0.753* 0.690* 0.277* 0.192† 0.283*
p 0.00 0.00 0.00 0.00 0.00 0.001 0.029 0.001
p† 0.086 0.097 0.163 0.764 0.154 0.635 0.023 0.078
Insulin
r 0.920* 0.944* 1 0.935* 0.754* 0.720* 0.243* 0.163 0.267*
p 0.00 0.00 0.00 0.00 0.00 0.005 0.064 0.002
p† 0.334 0.097 0.186 0.239 0.644 0.512 0.096 0.086
WHtR
r 0.846* 0.905* 0.935* 1 0.876* 0.811* 0.452* 0.314* 0.448*
p 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
p† 0.242 0.163 0.186 0.533 0.155 0.088 0.274 0.085
WC (cm)
r 0.648* 0.753* 0.754* 0.876* 1 0.688* 0.658* 0.604* 0.608*
p 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
p† 0.974 0.764 0.239 0.533 0.256 0.422 0.168
BMI  
(kg/m2)
r 0.669* 0.690* 0.720* 0.811* 0.688* 1 0.051 0.222* - 0.106
p 0.00 0.00 0.00 0.00 0.00 0.525 0.005 0.184
p† 0.399 0.154 0.644 0.155 0.256 0.067 0.278 0.205
WHR
r 0.164 0.277* 0.243* 0.452* 0.658* 0.051 1 0609* 0.832*
r 0.061 0.001 0.005 0.00 0.00 0.525 0.00 0.00
p† 0.377 0.635 0.512 0.088 0.533 0.067 0.533 0.090
NC (cm)
r 0.114 0.192† 0.163 0.314* 0.604* 0.222* 0.609* 1 0.444*
p 0.197 0.029 0.064 0.00 0.00 0.005 0.00 0.00
p† 0.377 0.023 0.064 0.274 0.422 0.278 0.533 0.067
BSI
r 0.197† 0.283* 0.267* 0.448* 0.608* - 0.106 0.832* 0.444* 1
p 0.024 0.001 0.002 0.00 0.00 0.184 0.00 0.00
p† 0.019 0.078 0.086 0.085 0.168 0.205 0.090 0.067
r = Pearson coefficient; WHtR = waist-to-height ratio; WC = waist circumference; BMI = body mass index; WHR = waist-to-hip ratio; NC = neck circumference; 
BSI = body shape index. *Significant correlations for all subjects; †Significant correlations for females versus males.  
Table 4. Multiple regression analysis on obesity indices that predict insulin resistance
Dependent variable Predictors β 95% CI R2 P
HOMA-IR waist-to-height ratio 0.53* 0.47-0.59 0.71 < 0.01
HOMA-β waist-to-height ratio 5.30* 4.93-5.67 0.82 < 0.01
Insulin (IU/ml) waist-to-height ratio 1.14* 1.04-1.25 0.73 < 0.01
WHtR = waist-to-height ratio; HOMA-IR = homeostasis model assessment - insulin resistance; HOMA-β = homeostasis model assessment - beta-cell function.
*WHtR values are expressed in percentage. Models adjusted for age, sex, weight, waist circumference, neck circumference, body mass index, waist-hip ratio, 
waist-to-height ratio and body shape index.
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body of literature showed that this abdominal obesity indicator 
could predict the cardiometabolic risk even better than BMI and 
WC.25 A recent meta-analysis on studies evaluating different 
indices of adiposity showed that WHtR was a better predictor 
for hyperinsulinemia, diabetes, arterial hypertension, dyslip-
idemia, metabolic syndrome and other cardiovascular health 
problems than were BMI or WC, in both men and women.26 
In addition, our AUC values for this anthropometric obesity 
indicator were higher than in previous prediction studies with 
WHtR,11,27,28 thus emphasizing the accuracy of AUC measure-
ments for identifying IR in obese populations. According to 
Behboudi-Gandevani et al.,11 WHtR may be proposed as a sen-
sitive, inexpensive, noninvasive, simple-to-assess and easy-to-
calculate tool for screening for IR. 
Taking into account that ethnicity and gender may influence 
body composition, studies on Brazilian and Indian overweight 
women also showed that the WHtR was the most important 
predictive measurement for IR and diabetes.27,29 However, stud-
ies on men of different ethnicity indicated that BMI was the 
best predictor for IR.28,30,31 It should be noted that BMI is char-
acterized as an indicator of general adiposity because of its 
inability to assess the distribution of body fat, thus presenting 
a weaker relationship with visceral fat.27 In a recent meta-anal-
ysis, Savva et al.32 compared the association of BMI and WHtR 
with the cardiometabolic risk factor of diabetes in Asian and 
non-Asian populations. The data from cross-sectional studies 
indicated that WHtR is superior to BMI for detecting diabe-
tes in both Asian and non-Asian populations. There are still 
few studies of this design on Brazilian populations, especially 
in relation to obese individuals.32
The risk of developing obesity-related comorbidities is pro-
portional to the degree of obesity and, more specifically, the 
accumulation of visceral fat.33 However, the presence of meta-
bolic disorders varies considerably among obese individuals,34 
since it is known that there is one subgroup of obese individuals 
that seems to be protected against or is more resistant to devel-
oping cardiometabolic complications.35 Nevertheless, regarding 
phenotypes for metabolic status and diabetes, healthy obese and 
metabolically unhealthy normal-weight individuals appear to 
have an equivalent risk.36 
In the general population, a WHtR cutoff < 0.5 is recommended, 
which can be presented as a simple public health message that indi-
viduals should seek to maintain their WC as less than half of their 
height. We showed that the higher this ratio is, the higher the risk 
of indirect IR is, and we proposed a cutoff > 0.65 to identify IR in 
non-diabetic obese individuals. This indicates that there is a need 
for a specific evaluation on this population, for early detection of 
IR that could ultimately reduce the incidence or severity of dia-
betes and cardiovascular diseases.
Figure 1. Receiver operating characteristic (ROC) curve for 
anthropometric parameters that predict insulin resistance 
according to the homeostatic model assessment-insulin resistance 
(HOMA-IR). The areas under the ROC curves and the 95% 
confidence intervals (95% CI) were 0.98 (0.95-0.99) for waist-to-
height ratio (WHtR); 0.93 (0.76-0.89) for waist circumference (WC); 






















Figure 2. Receiver operating characteristic (ROC) curve for 
anthropometric parameters that predict insulin resistance 
according to the homeostatic model assessment (HOMA)-β. 
The areas under the ROC curves and the 95% confidence 
intervals (95% CI) were 0.83 (0.76-0.89) for waist-to-height 
ratio (WHtR); 0.75 (0.67-0.82) for waist circumference (WC); 
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Table 5. Optimal cutoff point values and their related sensitivity, specificity, positive and negative likelihood ratios and Youden index for 








Waist-to-height ratio > 0.65 95.83 (89.7-98.9) 95.00 (83.1-99.4) 19.17 (5.0-74.0) 0.04 (0.02-0.1) 0.90
Waist circumference (cm) > 113.00 73.96 (64.0-82.4) 77.50 (61.5-89.2) 3.29 (1.8-5.9) 0.34 (0.2-0.5) 0.51
Body mass  
index (kg/m2)
> 38.76 67.71 (57.4-76.9) 80.00 (64.4-90.9) 3.39 (1.8-6.4) 0.40 (0.3-0.6) 0.47
HOMA-β
Waist-to-height ratio > 0.67 72.41 (61.8-81.5) 79.17 (65.0-89.5) 3.48 (2.0-6.1) 0.35 (0.2-0.5) 0.51
Waist circumference (cm) > 112.0 74.71 (64.3-83.4) 64.58 (49.5-77.8) 2.11 (1.4-3.2) 0.39 (0.3-0.6) 0.39
Body mass  
index (kg/m2)
> 37.61 82.76 (73.2-90.0) 62.50 (47.4-76.0) 2.21 (1.5-3.2) 0.28 (0.2-0.5) 0.45
HOMA-IR = homeostasis model assessment - insulin resistance; HOMA-β = homeostasis model assessment - beta-cell function; +LR = positive likelihood ratio; 
-LR = negative likelihood ratio.
In summary, we found that WHtR may be useful in clinical 
practice due to its advantageous simplicity. Also, it is easy to calcu-
late, does not require any special equipment other than an inelastic 
tape, and only requires some rater training.
The present study has limitations that should be considered. 
Our sample was not enough to extract the cutoff points according 
to sex. Since not all obese individuals have metabolic alterations, 
our strategy was to ascertain which anthropometric measurements 
were better correlated with IR, and whether non-diabetic obese 
individuals would present a cutoff point different from general 
population for predicting the onset of diabetes, thereby suggest-
ing different reference values for a more accurate assessment in 
this specific group. Perhaps inclusion of a eutrophic group would 
have contributed towards reinforcing our important findings. 
Future research should aim to screen Brazilian obese populations, 
in order to provide support for our remarks.
CONCLUSION
We can conclude that the WHtR is a strong predictor of IR, 
as assessed using HOMA, among non-diabetic obese adults. 
Our  results suggest that WHtR can form a simple and pow-
erful tool for screening for IR among these patients, since we 
found convincing AUC and sensitivity and specificity values 
for this index in detecting clinically high values of HOMA-IR 
and HOMA-β. 
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